ãã¹ã¯ã«ã¤ãã¦è°è«ãèµ·ãå§ãã¦ãããæ°åã³ããã®ææ対çã¨ãã¦ãæ¿åºãè¡æ¿ã¯ãã¹ã¯ã®çç¨ãå§ãã¦ãããããã¹ã¯çç¨ã®åãæ±ããå¤ãããã¨ããåãã ããã¹ã¯ã«ã¤ãã¦æ¹ãã¦èãã¦ã¿ããï¼ãã®è¨äºã¯2023/01/18æç¹ã®æ å ±ã«åºã¥ãã¦æ¸ãã¦ãã¾ãï¼ã é©åãªä¸ç¹å¸ãã¹ã¯ã®çç¨ã¨ã¯ å¼·å¶åãæã¤æ³çãªè¦å¶ã§ã¯ãªãããåçå´åçã¯ãã¹ã¯çç¨ã®ã¬ã¤ãã©ã¤ã³ã¨ãã¦ã人ã¨ã®è·é¢ãç®å®ã¨ãã¦2ã¡ã¼ãã«ä»¥å ã®å ´åãé¤ããå±å¤ã§ã¯å£ç¯ãåãããååä¸è¦ã¨ãã¦ãããããã¦å±å ã§ã¯ãè·é¢ï¼ç®å®ã¯2ã¡ã¼ãã«ï¼ã確ä¿ã§ããå³æ¸é¤¨å ãªã©ä¼è©±ãã»ã¨ãã©ããªãå ´åã«ã¯ãã¹ã¯çç¨ã®å¿ è¦ã¯ãªããã¨ããã åçå´åçããã¹ã¯ã®çç¨ã«ã¤ãã¦ããã ä¸æ¹ãå ±éã«ããã°ã岸ç°æéç·ç大è£ã¯2023å¹´1æ20æ¥ãæ°åã³ããã¦ã¤ã«ã¹ææçãå£ç¯æ§ã¤ã³ãã«ã¨ã³ã¶ãªã©ã¨åãæææ³ã«ãããäºé¡ã«ç§»è¡ããããã®æ¤è¨ãå è¤åä¿¡åçå´å大è£ã«æ示ã
è¨28件ã®ç 究ãçµ±åçã«åæããã¡ã¿ã¢ããªã·ã¹ç 究ã«ãã£ã¦ãæ°ãã«ãäºéãæåãããã¨ã§é¢¨éªãã¤ã³ãã«ã¨ã³ã¶ãªã©ã®ã¦ã¤ã«ã¹æ§å¼å¸å¨ææçãäºé²ãããä¸ã«æææéãç縮ããããã¨ããå¯è½æ§ã示åããã¾ãããç 究è ã¯ä»åã®ç 究ã«ã¯è¤æ°ã®åé¡ç¹ãããã¨æã£ãä¸ã§ãäºéã«ã¯é¢¨éªã®æéãç縮ããå¯è½æ§ãããã¾ããã¾ããçç¶ã®ãã¼ã¯æã«ããã2ï½4æ¥ç®ã«ãããéç度ã軽æ¸ããå¯è½æ§ããããã¨ã示ãã·ã°ãã«ãå¤æ°çºè¦ããã¾ãããã¨è¿°ã¹ã¦ãã¾ãã Zinc for the prevention or treatment of acute viral respiratory tract infections in adults: a rapid systematic review and meta-analysis of randomised controlled trials | BMJ Open htt
æ°åã³ããã¦ã¤ã«ã¹ã»ãã«ã¿æ ªã®æµè¡ã§é£æ¥ã®ããã«å»çç¾å ´ã®çª®ç¶ãä¼ãããã¦ãããå»çæä¾ä½å¶ã®åé¡ãææãããªããæ¡å¤§ããªããªãé²ã¾ãªãã æ±äº¬é½ã¯æ¹æ£ææçæ³16æ¡ã®2ã«åºã¥ãæ°éç é¢ã¸ã®ååãè¦è«ãããå¹æã¯ããã®ã ããããä½ãããå¸äºã®å¤ãã®è¨ºçæãã¯ãªããã¯ã¯1å¹´å以ä¸ããç±ã®ããæ¹ã¯ä¿å¥æã¸é£çµ¡ããã¨å¼µãç´ããã¾ã¾ãé ¬ããããã¦æ°åã³ããã®è¨ºçã«ååãã¦ããªããå§åãååã®å ¬è¡¨ãããã§ã¯å¹ããªãã®ã§ã¯ãªããã ã¾ãã大è¦æ¨¡ç é¢ãçé¤æ½è¨ã¸ã®å¿æ´ãå¨å® çé¤è ã¸ã®ãªã³ã©ã¤ã³ã«ãã診çæ¯æ´ã¨ãã£ãç¨åº¦ã§ã¯ä¸ååã ãä¸è¬ã®è¨ºçæã®éæ¥å»ãã¤ã³ãã«ã¨ã³ã¶ã®å ´åã¨åæ§ã«å¤æ¥è¨ºçãå¾è¨ºã«å¿ããä½å¶ãä½ãå¿ è¦ããããä¸æ¹ã§ãåç§ä¼ã®å»å¸«ã®ä¸é¨ãç¥äºãªã©ã主張ããå½æ°ã¸ã®ããå¼·åãªæ´»åå¶éãããã¯ãã¦ã³ãªã©ã¯ãã¹ãã§ãªãã以ä¸ã説æãããã ææåãå¼·ããªãä¸æ¹ãè´æ»çã¯ä½ä¸ ã¾ããæ°åã³ããã®è¢«
ææåã®å¼·ãæ°åã³ããã¦ã¤ã«ã¹ã®ãã«ã¿å¤ç°æ ªã®æ¡å¤§ãåãã¦ä»ãç±³å½ã§è°è«ã®çã«ãªã£ã¦ããã®ããRTOåé¡ãã ã RTOã¨ã¯ãReturn to Officeï¼ä¼ç¤¾ã«å¾©å¸°ããï¼ãã®ç¥ã§ãã°ã¼ã°ã«ã®æ¤ç´¢ã«ãreturnãã¨æã¡è¾¼ãã¨RTOã表示ãããã»ã©ãå¤ãã®äººã®é¢å¿äºã«ãªã£ã¦ããã
åçï¼ãã»ã©ã®çç±ããªãéãã¯ãæ¥ç¨®ãããã¨ããå§ããã¾ã æ¥æ¬ã§æ¿èªããã¦ããmRNAã¯ã¯ãã³ã«ã¯ãæ°åã³ããã¦ã¤ã«ã¹ã¸ã®ææã»çºçã»éçåã»æ»äº¡ãªã¹ã¯ãå¤§å¹ ã«æ¸ããå¹æã確èªããã¦ãã¾ããå®éã«æ°åã³ããã¦ã¤ã«ã¹ææçã«ç½¹ã£ã¦ãã¾ãããããã¯ããã«å°ããªãªã¹ã¯ã§å ç«ãç²å¾ã§ãã¾ãã ãã®ããããã»ã©ã®çç±ããªãéãã¯ãé çªãåã£ã¦ããæç¹ã§æ¥ç¨®ãããã¨ããå§ããã¾ãï¼ã¯ã¯ãã³æ¥ç¨®ã¯èªåã ãã§ãªããèªåã®å¨ãã®äººãå®ãã¨ããæ義ãããã¾ãï¼ã â»2023ï½2024å¹´ããããçãã«ãªãå§ãããã¯ã¯ãã³æ¥ç¨®ãå¾æããããããªããæ å ±ãã«ã¤ãã¦ã¯ãã¡ããåç §ãã¦ãã ããã â»ãã®è¨äºå 容ã¯æ¥ç¨®ãå¼·å¶ãããã®ã§ã¯ããã¾ãããæ¥ç¨®ãããã©ããã¯å人ã®å¤æã«å§ãããã¾ããããããäºå®èª¤èªããã¨ã«å¤æãã¦ãã¾ããã¨ããªããããè¬å±ã§ãè¡ã£ã¦ããæ å ±æä¾ã対å¿ãææ¸åãããã®ã§ãã â»é常ã«é·ãã®ã§ãã
è£ çè ã®å¿ææ°ãç®è温度ãªã©ã®ãã¤ãªãã¼ã«ã¼ã測å®ãããã¨ãå¯è½ãªã¹ãã¼ãã¦ã©ãããã¦ã§ã¢ã©ãã«ç«¯æ«ãç¨ãããã¨ã§ãæ°åã³ããã¦ã¤ã«ã¹ææç(COVID-19)ã®çç¶ãç¾ããåã«ææãæ¤åºãããã¨ãå¯è½ã§ãããã¨ãææ°ã®ç 究ã«ããæããã«ãªã£ã¦ãã¾ãã Smartwatches can help detect COVID-19 days before symptoms appear https://www.cbsnews.com/news/covid-symptoms-smart-watch/ ãã¥ã¼ã¨ã¼ã¯å¸ã®ç é¢ãããã¯ã¼ã¯ã§ããMount Sinai Health Systemãå«ã主è¦ãªå»çæ©é¢ãå¦è¡æ©é¢ã«ããè¤æ°ã®ç 究ã«ããã¨ãApple WatchãGarminãFitbitã¨ãã£ããã©ã³ãã®ã¹ãã¼ãã¦ã©ãããç¨ãããã¨ã§ãCOVID-19ã«é¢ããPCRæ¤æ»ã§é½æ§ã§ãããå¦ãã®å¤
ä¸çã®ææç¶æ³ âãã¡ãã®ãã¼ã¸ã§ã¯ãã¢ã¡ãªã«ã®ã¸ã§ã³ãºã»ãããã³ã¹å¤§å¦ãéè¨ããä¸çã®ææè æ°ã®ãã¼ã¿ããä¼ããã¦ãã¾ããããã¸ã§ã³ãºã»ãããã³ã¹å¤§å¦ã¯ã2023å¹´3æ10æ¥ã«ãã¼ã¿ã®æ´æ°ãçµäºãã¾ããã ã¢ã¡ãªã«ããã·ã¢ããã©ã³ã¹ãã¤ã¿ãªã¢ãä¸å½ãéå½ãªã©ä¸çåå½ã®æ°åã³ããã¦ã¤ã«ã¹ã®ææè æ°ã確èªã§ãã¾ãã å½ãå°åãã¨ã® ææè æ°ã®æ¨ç§» â»ãã®ã°ã©ãã§ã¯ãç±³ã¸ã§ã³ãºã»ãããã³ã¹å¤§å¦ã®éè¨ã§ç´¯è¨ã®ææè æ°ãå¤ã50ã®å½ãå°åã¨ãæ¥æ¬ã®è¿é£ã®ä¸å½ã»éå½ã«ã¤ãã¦è¡¨ç¤ºãã¦ãã¾ããåå½æ¿åºã®çºè¡¨ã¨æ°å¤ãç°ãªãå ´åãããã¾ãããã¼ã¿ã®ä¸ã«ã¯ãå¾æ¥ä¿®æ£ãè¡ãããç´¯è¨å¤ãåæ¥ããæ¸å°ãã¦ããã¨ãããããã¾ããã¾ããå¾æ¥ãéå»ã®ãã¼ã¿ãä¿®æ£ãããæ°å¤ãå¢æ¸ããå ´åãããã¾ãããã¼ã¿ãå ¥ã£ã¦ããªãæ¥ãããã¾ãã â»ã¤ã®ãªã¹æ¿åºã¯2022å¹´1æ31æ¥ã«éè¨æ¹æ³ãå¤æ´ããåææè ãã1æ¥ãã¨ã®çºè¡¨æ°ãã¨ã
æ°åã³ããã¦ã¤ã«ã¹ææç(COVID-19)ãçºè¦ããã¦ãã1å¹´ãçµéãããã¨ãã¦ãã2020å¹´12æ15æ¥ã«ãCOVID-19ã¨å£ç¯æ§ã¤ã³ãã«ã¨ã³ã¶ãå®å ¨ã«æ¡ä»¶ãããããåä¸ãªãã¼ã¿ã§æ¯è¼ããç 究çµæããã¤ã®ãªã¹ã®å»å¦èªBritish Medical Journalã«æ²è¼ããã¾ããããã®è«æã«ãããCOVID-19ã¨ã¤ã³ãã«ã¨ã³ã¶ã®æ»äº¡ãªã¹ã¯ãçç¶ã®éããæ¹ãã¦æµ®ã彫ãã¨ãªã£ã¦ãã¾ãã Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with covid-19 and seasonal influenza: cohort study | The BMJ https://www.bmj.com/content/371/bmj.m4677
æ¥æ¬å½å ã§ã®æ°åã³ããã¦ã¤ã«ã¹ææçã®æµè¡ã¯ç¬¬3æ³¢ãè¿ããæ°è¦ææè æ°ã¯é£æ¥éå»æé«ãæ´æ°ãã¦ãã¾ãã ãå»çå´©å£ãã®æ¸å¿µãåã¡ãã£ã¢ãããä¼ããããããã«ãªãã¾ããã å®éã«æ°åã³ããã®æµè¡ã«ãã£ã¦å»çå´©å£ãèµ·ãã£ã¦ãã¾ãã¨ãä½ãèµ·ããã®ã§ããããã æ¥æ¬å ¨å½ã®æ°åã³ããéçæ£è æ°ã¯ãã§ã«ç¬¬2æ³¢ãè¶ ãã¦ããæ°åã³ããéçè æ°ã®æ¨ç§»ï¼åçå´åçHPããï¼11æ20æ¥æç¹ã§ã®æ¥æ¬å ¨å½ã®æ°åã³ããéçæ£è æ°ã¯291人ï¼åæ¥æ¯ï¼11人ï¼ã¨ãªãã第2æ³¢ã®ãã¼ã¯æãæ©ããè¶ ãã¾ããã 第2æ³¢ã¨æ¯ã¹ã¦ç¬¬3æ³¢ã§ã¯é«é½¢è ãå ããå²åãå¤ããã¨ãããéçè æ°ã®å¢å ã®ãã¼ã¹ã第2æ³¢ãä¸åã£ã¦ãã¾ãã ã¾ããæ°åã³ããã¯è¨ºæããã¦ããéçåããã¾ã§ã«æéãããããã¨ãããããã¾ã§ã®ç¬¬1æ³¢ã第2æ³¢ã§ãéçè æ°ã®ãã¼ã¯ã¯æ°è¦ææè æ°ã®ãã¼ã¯ãããç´1é±éé ãã¦ãã£ã¦ãã¦ãã¾ãã 第3æ³¢ã¯ã¾ã æ°è¦ææè æ°ã®ãã¼ã¯ãè¶
æ¯æ¥æ°èã®ãã¥ã¼ã¹ãµã¤ãã«æ²è¼ã®è¨äºã»åçã»å³è¡¨ãªã©ç¡æ転è¼ãç¦æ¢ãã¾ããèä½æ¨©ã¯æ¯æ¥æ°è社ã¾ãã¯ãã®æ å ±æä¾è ã«å±ãã¾ãã ç»åãã¼ã¿ã¯ï¼æ ªï¼ãã©ã¼ã«ã¹ã·ã¹ãã ãºã®é»åéãããacuagraphyãã«ããèä½æ¨©æ å ±ã確èªã§ããããã«ãªã£ã¦ãã¾ãã
調æ»æéã«ããããã¬ã¯ã¼ã¯å°å ¥çã«ã¯å°åãæ¥ç¨®ã®å·®ãã¿ãããå°åå¥ã§ã¯é¢æ±ï¼54.3ï¼ ï¼ãæ¥ç¨®å¥ã«ã¯éä¿¡ã»æ å ±ãµã¼ãã¹é¢é£ä¼æ¥ï¼62.3ï¼ ï¼ã¨çªåºãããã®ã«ãã¾ããå¤è³ç³»ä¼æ¥ã¨æ¿åºã»å ¬å ±æ©é¢ã§ã¯ããããåæ°å¼·ããã¬ã¯ã¼ã¯ãå°å ¥ããå¤è³ç³»ä¼æ¥ã§ã¯é±ã®åå以ä¸ããã»ã¼å®å ¨ã«ãªã¢ã¼ãã§åãã¦ãã人ãå¤ãã®ã«å¯¾ãã¦ãæ¿åºã»å ¬å ±æ©é¢ãªã©ã§ã¯ãé±ã«2æ¥ä»¥å ã®é¨åçãªå®æ½ã«ã¨ã©ã¾ãã¨ããåçãå¤æ°ã¨ãªã£ããã¾ãããã¬ã¯ã¼ã¯ãå®æ½ãã¦ããªã人ã®54ï¼ ãããã¬ã¯ã¼ã¯ã§ããæ¥åãå ¨ããªãã¨åçãã¦ããã ãã¬ã¯ã¼ã¯å®æ½ä¸ã®å°ããã¨ã¨ãã¦ã¯ã社å¤ããã®ã¢ã¯ã»ã¹ãã§ããªãï¼ãã«ããï¼ãã¡ã¤ã«ã®é²è¦§ãç´ã®è³æã®ç¢ºèªãæ¼å°ä½æ¥ãä¸ä¾¿ã§ãã£ãããã«åºç¤¾ãè¦ããã¨ããäºæ ãæããããã¨ãã«60代ã¨40代ã®åçè ã®ç´4å²ãç´ã®æ¸é¡ã®ç¢ºèªã«ãã¾ãã20代ã®åçè ã®44.8ï¼ ãã社å¤ããã¢ã¯ã»ã¹ã§ããªããã¡ã¤ã«ã®é²è¦§ã«èª²é¡ãæ
é·æéã®ãã¹ã·ã¼ã³ã ã¨ã¬ã¤ã³ãã¼ããªãã¸ã赤ããªããã!?ãRyanKing999 - iStockphoto ï¼å¤§æ²³ãã©ããéºéºãããããå代æªèã®æ¾æ ä¼æ¢ã«è¿½ãè¾¼ãã æ°åã³ããããã©ããæ ç»ã®æ®å½±ç¾å ´ã¯ã©ããªãã®ãââï¼ æ°åã³ããã¦ã¤ã«ã¹ã®ä¸ççãã³ãããã¯ã¯ãããã¾ã§ã®å¸¸èãè¦ããã¾ã£ããæ°ããæ¥å¸¸ã®å§¿ãå®çããããã¨ãã¦ãããæ åã®ä¸çã§ãæ®å½±ä¼æ¢ãªã©ã³ããã®å½±é¿ã大ããåãã¦ããããææäºé²ã®çãç·´ããã¦ãä¼æ¢ãã¦ããæ®å½±ãå¾ã ã«åéããããã¨ãã¦ããã æ¥æ¬ã®åãã¬ãå±ã¯ãã©ããªã©ã®æ®å½±åéã«ããã£ã¦ãç¾å ´ã§ã®ã¬ã¤ãã©ã¤ã³ãä½ã£ã¦ããããã ããææ´ãããããè·é¢ãä¿ã¡ãæ¥è§¦ã¯é¿ããããªã©åºæ¬çäºé²çã¯ãã¡ããã ããããããã¯ä¸å¯ãé¿ããããããªã¼ãã£ã·ã§ã³ã¯ãªã¢ã¼ããæ¨å¥¨ãããããã«ãªã£ãã ã¾ããããã¾ã§å¸¸èã¨ããã¦ããé¡åãããèªã¿åããã¯ãååã¨ãã¦è¡ãããªããªãããã£
ï¼å³ããããã¿ãããã¨ãã«åºãé£æ²«ãé£ã¶ãã¨ã¯ç¥ããã¦ããããé常ã®ãããã¹ãã§ãé£æ²«ãé£ã¶ãã¨ãããã£ã......ï¼ ç¡çç¶ææè ã¨ã®ä¼è©±ãææçµè·¯ã«ï¼ ãããã¹ããããã¨ããå£ããé£ã³åºããé£æ²«ã¯ããã®å¾ç©ºä¸ã«8å以ä¸æ¼ã£ã¦ãããã¨ããææ°ã®å®é¨ã«ããæããã«ãªã£ããç±³ãã³ã·ã«ããã¢å¤§å¦ãç±³å½ç«è¡çç 究æï¼NIHï¼ã®ç 究è ããè¡ã£ããã®ã§ãçµæã¯ç±³å½ç§å¦ã¢ã«ããã¼ç´è¦ï¼PNASï¼ã«æ²è¼ããã¦ããã æ°åã³ããã¦ã¤ã«ã¹ãªã©ã®å¼å¸å¨ç³»ã¦ã¤ã«ã¹ã¯ãå³ããããã¿ãããã¨ãã«åºãé£æ²«ããææãããã¨ã¯ãå¤ãã®äººãç¥ã£ã¦ããããããç 究è ãã¯ãé常ã®ãããã¹ãã§ãé£æ²«ãé£ã¶ãã¨ã¯ããã¾ã§ç¥ããã¦ããªãã¨ææãã¾ããæ°åã³ããã¦ã¤ã«ã¹ã®ç¡çç¶ææè ãä¼è©±ããã¦ããã¨ãã«é£ãã é£æ²«ããææçµè·¯ã«ãªã£ãã¨èããããã±ã¼ã¹ãå¢ãã¦ãããã¨èª¬æãã¦ããã ããã§ç 究ãã¼ã ã¯ãã¬ã¼ã¶ã¼å æ£ä¹±æ³ã使ãã人ã話
ã¯ããã«ç·æ¥ã¬ãã¼ãã¨ããå½¢ã§æ¸ãã¦ãããæ°åã³ããã¦ã¤ã«ã¹ã«ã¤ãã¦ãã¯ã大ããªåããç¡ãéãä¼è¼ãããããã®æ¿æ²»ãçµæ¸ã社ä¼ãã©ããªããã«ã¤ãã¦ãæ°å¸¸æ (New Normal) ãå°ãã¥ã¤ç¢ºå®ã«å¤ããä¸çããã®ãã¬ã¸ã³ã§æ¸ãã¦ãããã¨æãã¾ãã 1. ç§éãçµé¨ããéæ¥å¸¸ã¨æ¿ãã移ããæèãã®æç« ã¯å人çãªåå¿é²ã«è¿ããç·æ¥äºæ 宣è¨ãææ¥ããæããããã®åå¤ãä»ããæ¸ããªãæ°ããã¦æ¸ãã¦ããã 1ææ«ã®æ¦æ¼¢é½å¸å°éã2æã®ãã¤ã¤ã¢ã³ãããªã³ã»ã¹å·ããã®ä¸æä¼æ ¡è¦è«ã3ææ«é£ä¼æãã®å°æ± é½ç¥äºã®ããã¯ãã¦ã³ä¼è¦ããã®4æç·æ¥äºæ å®£è¨ ãã®4ã¶æéãç§éã¯å®ã«å¤ãã®ãã¨ãåãã¦çµé¨ããã 社ä¼å ¨ä½ãå人çæ´»ãæ¯æ¥ãéæ¥å¸¸ã ã£ãã æ¥ã®ã»ã³ããã®ä¸æ¢ã決å®ãããæã¯é©ãããã§ãå¤ã®é«æ ¡éçãä¸æ¢ã«ãªã£ã¦ãããé©ããªããï¼ææ«å¦æ ¡ã®ä¸æä¼æ ¡è¦è«ãæ¥ãæã¯ãï¼æåæ¥å¼ãã§ããªãã£ãããããããã¨å¿
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}